Barclays’s PHARMACYCLICS INC PCYC Stock Holding History

Barclays’s Portfolio PCYC Stock Details PCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-189,579	Closed	-$48.3M	–	7462
2015 Q1	$48.3M	Buy	189,579 +174,649	+1,170%	+$33.7M	0.06%	335
2014 Q4	$1.82M	Sell	14,930 -45,760	-75%	-$5.85M	﹤0.01%	2612
2014 Q3	$7.1M	Buy	60,690 +2,821	+5%	+$321K	0.01%	1459
2014 Q2	$5.15M	Sell	57,869 -14,105	-20%	-$1.32M	0.01%	1713
2014 Q1	$7.2M	Sell	71,974 -139,717	-66%	-$18.2M	0.01%	1415
2013 Q4	$22.2M	Buy	211,691 +196,113	+1,259%	+$23.8M	0.02%	714
2013 Q3	$2.15M	Sell	15,578 -130,160	-89%	-$14.4M	﹤0.01%	2485
2013 Q2	$11.6M	Buy	+145,738	New	+$11.9M	0.01%	983

Other funds holding PCYC

Credit Agricole Montrouge Cedex, France $38.1B AUM

Barclays's PCYC Position: Q2 2015 in Review

Barclays sold out of PHARMACYCLICS INC (PCYC) in Q2 2015, closing a stake of 189,579 shares — an estimated $48.3M sold.

Barclays first reported a position in PCYC in Q2 2013 and held it in 8 quarters. The position peaked at $48.3M in Q1 2015. 1 fund tracked by Wall St. Rank holds PCYC as of Q2 2015.

Barclays reported no remaining PHARMACYCLICS INC position as of Q2 2015 after selling out during the quarter.
Barclays sold 189,579 PHARMACYCLICS INC shares in Q2 2015, an estimated $48.3M.
Barclays first reported a position in PHARMACYCLICS INC in Q2 2013 and held it in 8 quarters.
Barclays's PHARMACYCLICS INC position peaked at $48.3M in Q1 2015.
1 fund tracked by Wall St. Rank held PHARMACYCLICS INC as of Q2 2015.

Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.